Page 70 - product-manual

TM/MC TM/MC
REFERENCES

Abdel TM, Werz O, Schubert-Zsilavecz M. (2011). Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clinical
Pharmacokinetics. 50:349-69.

Adedapo AA, Mogbojuri OM, Emikpe BO. (2009). Saftey evaluations of the aqueous extract of the leaves of Moringa olefera in rats. Journal of Medicinal Plants Research.
3:586-591.

Anwar F, Latif S, Ashraf M, Gilani AH. (2007). Moringa oleifera: a food plant with multiple medicinal uses. Phytotherapy Research. 21:17-25.

Aragon CL, Hofmeister EH, Budsberg SC. (2007). Systematic review of clinical trials of treatments for osteoarthritis in dogs. Journal of the American Veterinary Medical
Association. 230:514-21.

Baeurle SA, Kiselev MG, Makarova ES, Nogovitsin EA. (2009). Effect of the counterion behavior on the frictional – compressive properties of chondroitin sulfate solutions.
Polymer. 50:1805-1813.

Beresford T. (2002) The Chemistry & Pharmacology of Harpagophtum procumbens. Australian Naturopathic Network. Accessed: November 29, 2011. Available at: http://
www.ann.com.au/features/harpago.htm

Cheenpracha S, Park EJ, Yoshida WY, et al. (2010). Potential anti-inflammatory phenolic glycosides from the medicinal plant Moringa oleifera fruits. Bioorganic & Medicinal
Chemistry. 18:6598-602.

Chen JK, Chen TT. (2004). Chinese Medical Herbology and Pharmacology. California (USA): Art of Medicine Press.

D’Altilio M, Peal A, Alvey M, et al. (2007). Therapeutic efficacy and safety of undenatured Type II Collagen singly or in combination with Glucosamine and Chondroitin in
arthritic dogs. Toxicology Mechanism and Methods. 17:189-96.

ESCOP Monographs. (2009): The Scientific Foundation for Herbal Medicinal Products. Second Edition, Supplement. New York (USA): Thieme.

European Medicines Agency. (EMEA) (2009). Evaluation of Medicines for Human Use. Assessment Report on Harpagophytum procumbens DC. and/or Harpagophytum
zeyheri Decne, Radix. London (UK): EMEA/HMPC/251324/2006.

Ganju L, Karan D, Chanda S, et al. (2003). Immunomodulatory effects of agents of plant origin. Biomed & Pharmacotherapy. 57:296-300.

Horváth K, Noker PE, Somfai-Relle S, Iet et al. (2002). Toxicity of methylsulfonylmethane in rats. Food and Chemical Toxicology. 40:1459-62.

Jaijoy K, Soonthornchareonnon N, Lertprasertsuke N, et al. (2010). Acute and chronic oral toxicity of standardized water extract from the fruit of Phyllanthus emblica Linn.
International Journal of Applied Research in Natural Products. 3:48-58.

Knudsen JF, Sokol GH. (2008). Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and
MedWatch database. Pharmacotherapy. 28:540-8.

Krishnaveni M, Mirunalini S. (2010). Therapeutic potential of Phyllanthus emblica (amla): the ayurvedic wonder. Journal of Basic and Clinical
Physiology and Pharmacology. 21:93-105.

Kunnumakkara AB, Nair AS, Sung B, et al. (2009). Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple
myeloma via the protein tyrosine phosphatase SHP-1. Molecular Cancer Research. 7:118-128.

Langmead L, Dawson C, Hawkins C, et al. (2002). Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study. Alimentary
Pharmacology & Therapeutics. 16:197-205.

Articulare-VM TM | 9